Our studies, which have not examined the physiological effects of DGKδ dysfunction, indicate that additional investigations are required to define the cells and tissues via which impaired DGKδ-mediated signal transduction via the CaSR and other GPCRs may cause increased kidney stone risk. The gene discussed is CASR; the disease is nephrolithiasis.